María Asunción Esteve‐Pastor

Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry

Martín Ruiz Ortiz, Javier Muñiz, P Rana Miguez et al. · EP Europace · 2017 · 121 citations · Full text

Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology

David Vivas, Vanessa Roldán, María Asunción Esteve‐Pastor et al. · Revista Española de Cardiología (English Edition) · 2020 · 91 citations · Full text

Thrombosis, Cardiovascular Thrombosis, Long Covid +9

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

José Miguel Rivera‐Caravaca, Vanessa Roldán, María Asunción Esteve‐Pastor et al. · Thrombosis and Haemostasis · 2017 · 86 citations

Heart Failure, Important Risk Factor, Cerebrovascular Disease +21

Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Alena Shantsila et al. · Thrombosis and Haemostasis · 2017 · 61 citations

Hypertension, Modifiable Risk Factors, Bleeding Risk +23

Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores

Vanessa Roldán, Vicente Vicente, Mariano Valdés et al. · Thrombosis and Haemostasis · 2017 · 60 citations